Canaan Partners X LLC, 10% Owner at Protagonist Therapeutics, Inc (PTGX), sold 24,906 shares at $20.64 ($514K) on 2018-03-15, disclosed to the SEC on 2018-03-15.
Open-market sale of $514k PTGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.84 | 1,204 | $25K | 4.9% |
| 2 | $20.77 | 200 | $4K | 0.8% |
| 3 | $20.64 | 11,751 | $243K | 47.2% |
| 4 | $20.64 | 11,751 | $243K | 47.2% |
| Total | $20.65 avg | 24,906 | $514K | 100% |
| Filing → |
| PTGX | SELL | 2018-03-26 | $2.5M | — | Filing → |
| PTGX | SELL | 2018-03-19 | $837K | — | Filing → |